Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70151 - 70175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CYTIP	9595	downregulated	Silicon Dioxide analog results in decreased expression of CYTIP mRNA	2q24.1	A24195
Silicon dioxide	Approved	CYTOR	112597	upregulated	Silicon Dioxide analog results in increased expression of CYTOR mRNA	2p11.2	A24195
Silicon dioxide	Approved	CYYR1	116159	upregulated	Silicon Dioxide analog results in increased expression of CYYR1 mRNA	21q21.3	A24194
Silicon dioxide	Approved	DAB2	1601	upregulated	Silicon Dioxide results in increased expression of DAB2 mRNA	5p13.1	A24196
Silicon dioxide	Approved	DAB2IP	153090	downregulated	Silicon Dioxide analog results in decreased expression of DAB2IP mRNA	9q33.2	A24195
Silicon dioxide	Approved	DACT1	51339	downregulated	Silicon Dioxide analog results in decreased expression of DACT1 mRNA	14q23.1	A24195
Silicon dioxide	Approved	DACT2	168002	downregulated	Silicon Dioxide analog results in decreased expression of DACT2 mRNA	6q27	A24195
Silicon dioxide	Approved	DACT3	147906	downregulated	Silicon Dioxide analog results in decreased expression of DACT3 mRNA	19q13.32	A24195
Silicon dioxide	Approved	DAG1	1605	downregulated	Silicon Dioxide results in decreased expression of DAG1 mRNA	3p21.31	A24196
Silicon dioxide	Approved	DAND5	199699	downregulated	Silicon Dioxide analog results in decreased expression of DAND5 mRNA	19p13.13	A24195
Silicon dioxide	Approved	DAPP1	27071	upregulated	Silicon Dioxide results in increased expression of DAPP1 mRNA	4q23	A24196
Silicon dioxide	Approved	DAW1	164781	downregulated	Silicon Dioxide analog results in decreased expression of DAW1 mRNA	2q36.3	A24194
Silicon dioxide	Approved	DAW1	164781	upregulated	Silicon Dioxide analog results in increased expression of DAW1 mRNA	2q36.3	A24195
Silicon dioxide	Approved	DBF4B	80174	upregulated	Silicon Dioxide analog results in increased expression of DBF4B mRNA	17q21.31	A24195
Silicon dioxide	Approved	DBIL5P2	100169989	downregulated	Silicon Dioxide analog results in decreased expression of DBIL5P2 mRNA	2p15	A24194
Silicon dioxide	Approved	DBP	1628	downregulated	Silicon Dioxide analog results in decreased expression of DBP mRNA	19q13.33	A24195
Silicon dioxide	Approved	DCAF11	80344	downregulated	Silicon Dioxide analog results in decreased expression of DCAF11 mRNA	14q12	A24195
Silicon dioxide	Approved	DCAF11	80344	downregulated	Silicon Dioxide results in decreased expression of DCAF11 mRNA	14q12	A24196
Silicon dioxide	Approved	DCAF13	25879	upregulated	Silicon Dioxide analog results in increased expression of DCAF13 mRNA	8q22.3	A24195
Silicon dioxide	Approved	DCAF17	80067	downregulated	Silicon Dioxide results in decreased expression of DCAF17 mRNA	2q31.1	A24196
Silicon dioxide	Approved	DCK	1633	upregulated	Silicon Dioxide analog results in increased expression of DCK mRNA	4q13.3	A24195
Silicon dioxide	Approved	DCLK1	9201	upregulated	Silicon Dioxide analog results in increased expression of DCLK1 mRNA	13q13.3	A24195
Silicon dioxide	Approved	DCLK3	85443	upregulated	Silicon Dioxide analog results in increased expression of DCLK3 mRNA	3p22.2	A24194
Silicon dioxide	Approved	DCLRE1C	64421	downregulated	Silicon Dioxide results in decreased expression of DCLRE1C mRNA	10p13	A24196
Silicon dioxide	Approved	DCP1A	55802	upregulated	Silicon Dioxide results in increased expression of DCP1A mRNA	3p21.1	A24196

Displaying entries 70151 - 70175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability